ThermoGenesis (KOOL) Receives AXP, BioArchive Implementation Commitment in China
Tweet
Share
E-mailGet Alerts KOOL Hot Sheet
Join SI Premium – FREE
ThermoGenesis Corp. (Nasdaq: KOOL) reports that BoyaLife has become the largest operating cord blood banking organization in the country to commit to the implementation of its AXP AutoXpress (AXP) and BioArchive Systems used to process and store stem cells from cord blood.
BoyaLife is one of the Company's three cord blood products customers in China. Two other operators of cord blood stem cell banks in China, Beike Biotechnology (Beike) and Nanshan Memorial Medical Institute (Nanshan), have recently purchased AXP and BioArchive Systems from ThermoGenesis and will be installing them in the near future.
BoyaLife is one of the Company's three cord blood products customers in China. Two other operators of cord blood stem cell banks in China, Beike Biotechnology (Beike) and Nanshan Memorial Medical Institute (Nanshan), have recently purchased AXP and BioArchive Systems from ThermoGenesis and will be installing them in the near future.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Cytek faces $56M damages award in Beckman Coulter patent case
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
